The L-arginine:nitric oxide pathway

S. Moncada, E. A. Higgs, H. F. Hodson, R. G. Knowles, P. Lopez-Jaramillo, T. McCall, R. M.J. Palmer, M. W. Radomski, D. D. Rees, R. Schulz

Research output: Articles / NotesScientific Articlepeer-review

93 Scopus citations

Abstract

Nitric oxide (NO) is synthesized from L-arginine by an enzyme called the NO synthase. NO production by vascular endothelial cells accounts for the biological properties of endothelium-derived relaxing factor and maintains a vasodilator tone. Platelets also produce NO, which modulates their aggregability. In the central nervous system NO mediates the effects of excitatory amino acids. In all these tissues the L-arginine:NO pathway acts as a transduction mechanism for the soluble guanylate cyclase, for which NO is the endogenous stimulator. NO is also released after immunological stimulation in macrophages, neutrophils, and other cells. NO thus released acts as part of the host defense mechanism, for it is cytotoxic or cytostatic for tumor cells and invasive organisms and may mediate other aspects of the immunological response. Discovery of the L-arginine:NO pathway has far reaching implications for the understanding of several areas in biology and indicates potential novel therapies for a number of diseases.

Original languageEnglish
Pages (from-to)S1-S9
JournalJournal of Cardiovascular Pharmacology
Volume17
Issue numberSUPPL. 3
DOIs
StatePublished - 1991
Externally publishedYes

Keywords

  • Endothelium-derived relaxing factor
  • L-arginine
  • Nitric oxide

Fingerprint

Dive into the research topics of 'The L-arginine:nitric oxide pathway'. Together they form a unique fingerprint.

Cite this